Stimulant use disorder

Research Update

Add-On Buprenorphine for Methamphetamine Use Disorder

Topics: Buprenorphine | Methamphetamines | Stimulant use disorder

REVIEW OF: Kheirabadi GR et al, J Clin Psychopharmacol 2021;41(1):45–48 STUDY TYPE: Randomized controlled trial Methamphetamine (meth) addiction is notoriously difficult to treat. There are no FDA-approved medications, and even the most promising trials have mixed results. People withdrawing from meth experience dysphoria, anxiety, mood instabil

Read More